
Ardavanis A, Tryfonopoulos D, Orfanos G, Karamouzis M, Scorilas A, Alexopoulos A, Rigatos G: Safety and Efficacy of Trastuzumab Every 3 Weeks Combined with Cytotoxic Chemotherapy in Patients with HER2-Positive Recurrent Breast Cancer: Findings from a Case Series. Onkologie 2005;28:558-564 (DOI: 10.1159/000088608)
Free Abstract
|
|
Login (Subscriber / Returning Pay-per-View Customer)
|
|
| New Pay-per View Customer |
|
|
|
Pay-per-View Options:
• NEW: Payment on account
With a Karger Pay-per-View account (down payment USD 100.00)
you profit from a special rate for this and other single items.
This item at the discounted price: USD 21.00
or
• Direct payment This item at the regular price: USD 30.00
|
|
|
|
 |
| Search in this issue
|
|
|

|

For non-native English speakers and international authors who would like assistance with their writing before submission, we suggest American Journal Experts for their scientific editing service. |
|
|